Clinical Trials | September 16, 2025
Novo Nordisk’s amylin therapy cagrilintide shows significant weight loss in phase 3 trial
Cagrilintide represents a novel approach to obesity management
Cagrilintide represents a novel approach to obesity management
Both will develop a non-viral manufacturing workflow designed to eliminate key bottlenecks and accelerate the delivery of lifesaving engineered cell therapies to patients
Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows
Launched in Thailand, the ASEAN hub, marking an early entry into the fast-growing combination therapy market (DPP-4 and SGLT-2 inhibitor combination) with strong potential for market leadership
First-of-its-kind active cosmetic ingredient directly activates the oxytocin receptor, mimicking the dermatological effects of being in love
Aster commits to increase bed capacity in the State via capacity expansion and greenfield projects
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
Subscribe To Our Newsletter & Stay Updated
